120
Participants
Start Date
February 10, 2025
Primary Completion Date
April 30, 2025
Study Completion Date
May 31, 2025
Remimazolam
participants in the remimazolam group received remimazolam besylate intravenously at an initial infusion rate of 0.2mg/kg/h and adjusted (maximum of 2 mg/kg/h) to maintain a Richmond Agitation-Sedation Scale(RASS) score between - 2 and 0.If the maximum dose of remimazolam was insufficient to sedate, add rescue dexmedetomidine.
Propofol
participants in the propofol group received propofol intravenously at an initial infusion rate of 1 mg/kg/h and adjusted (maximum of 4 mg/kg/h) to maintain a Richmond Agitation-Sedation Scale (RASS) score between - 2 and 0.If the maximum dose of propofol was insufficient to sedate, add rescue dexmedetomidine.
RECRUITING
First afflilated hospital of zhejiang university school of medicine, Hangzhou
First Affiliated Hospital of Zhejiang University
OTHER